RK Capital Management (Colorado)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-151,617
| Closed | -$12.8M | – | 54 |
|
|
2018
Q4 | $12.8M | Buy |
151,617
+103,234
| +213% | +$8.74M | 3.65% | 9 |
|
|
2018
Q3 | $8.29M | Sell |
48,383
-33,503
| -41% | -$5.74M | 1.87% | 25 |
|
|
2018
Q2 | $10.6M | Buy |
81,886
+4,649
| +6% | +$601K | 2.33% | 16 |
|
|
2018
Q1 | $7.96M | Buy |
77,237
+15,068
| +24% | +$1.55M | 1.73% | 30 |
|
|
2017
Q4 | $5.31M | Sell |
62,169
-73,578
| -54% | -$6.29M | 1.12% | 46 |
|
|
2017
Q3 | $11.5M | Sell |
135,747
-145,873
| -52% | -$12.4M | 2.69% | 11 |
|
|
2017
Q2 | $21.3M | Sell |
281,620
-7,694
| -3% | -$583K | 4.29% | 1 |
|
|
2017
Q1 | $19.1M | Sell |
289,314
-18,274
| -6% | -$1.21M | 3.69% | 3 |
|
|
2016
Q4 | $19.5M | Buy |
307,588
+16,831
| +6% | +$1.07M | 4.04% | 5 |
|
|
2016
Q3 | $18.5M | Buy |
290,757
+93,615
| +47% | +$5.96M | 3.59% | 3 |
|
|
2016
Q2 | $14.7M | Sell |
197,142
-46,166
| -19% | -$3.43M | 2.62% | 13 |
|
|
2016
Q1 | $16.3M | Buy |
243,308
+38,151
| +19% | +$2.55M | 2.69% | 14 |
|
|
2015
Q4 | $13.9M | Buy |
205,157
+66,204
| +48% | +$4.48M | 2.42% | 18 |
|
|
2015
Q3 | $7.42M | Buy |
138,953
+85,280
| +159% | +$4.56M | 1.36% | 34 |
|
|
2015
Q2 | $3.38M | Sell |
53,673
-60,594
| -53% | -$3.81M | 0.61% | 51 |
|
|
2015
Q1 | $5.5M | Sell |
114,267
-210,474
| -65% | -$10.1M | 1.1% | 41 |
|
|
2014
Q4 | $10.8M | Buy |
324,741
+45,365
| +16% | +$1.51M | 2.13% | 23 |
|
|
2014
Q3 | $8.19M | Buy |
279,376
+80,069
| +40% | +$2.35M | 1.67% | 31 |
|
|
2014
Q2 | $7.75M | Buy |
199,307
+44,082
| +28% | +$1.71M | 1.54% | 35 |
|
|
2014
Q1 | $6.51M | Sell |
155,225
-61,715
| -28% | -$2.59M | 1.32% | 38 |
|
|
2013
Q4 | $7.12M | Buy |
216,940
+57,212
| +36% | +$1.88M | 1.75% | 31 |
|
|
2013
Q3 | $4.31M | Buy |
+159,728
| New | +$4.31M | 1.23% | 41 |
|